By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1055 E. Colorado Boulevard. Fifth Floor

Pasadena  California  91106  U.S.A.
Phone: 323-721-5500 Fax: 323-721-9131


Company News
Genervon Announces ALS Compassionate Use Results 1/8/2015 10:56:03 AM
Genervon Announces ALS And PD Phase 2a Trial Results 10/20/2014 9:29:21 AM
Genervon Announces Biomarker Data From GALS-001 Clinical Trial For ALS 6/30/2014 10:53:40 AM
Genervon Successfully Completes Its Phase 2a Clinical Trial For ALS 4/28/2014 11:14:58 AM
FDA Grants "Orphan Drug" Designation For Genervon’s Breakthrough Multi-Target ALS Bio-Drug GM604 3/3/2014 8:41:41 AM
FDA Granted Fast Track Designation for Genervon's Breakthrough Biotechnology Multi-Target ALS Drug GM604 Expediting Drug Approval Process 6/27/2013 10:40:15 AM
Multiple Target ALS Drug Ready for Genervon's Phase 2 Trial 5/21/2013 11:30:54 AM
Genervon Will Present at Biotech Showcase Mechanisms of Actions of GM604 on 30 ALS Genes 1/4/2013 6:32:20 AM
Genervon Established That Its Targeted Drug Benefits ALS Disorder Through 8 Pathways and Modulates Over 30 Specific ALS Genes Dynamically 12/13/2012 9:31:28 AM